臺北醫學大學人工智慧醫療研究中心

Medicine & Life Sciences

1. Taiwan 100%
2. Meta-Analysis 35%
3. Population 33%
4. Stroke 31%
5. Randomized Controlled Trials 24%
6. Cohort Studies 22%
7. Neoplasms 20%
8. Confidence Intervals 20%
9. Sleep 19%
10. Systematic Reviews 18%
11. Databases 17%
12. Therapeutics 15%
13. Dementia 14%
14. Exercise 14%
15. Odds Ratio 14%
16. Elderly 13%
17. Depression 13%
18. Proteins 12%
19. National Health Programs 12%
20. Control Groups 12%
21. Mortality 11%
22. Genes 11%
23. Health 11%
24. Renal Dialysis 11%
25. Apoptosis 11%
26. Wounds and Injuries 10%
27. Incidence 10%
28. Magnetic Resonance Imaging 10%
29. Breast Neoplasms 10%
30. Nurses 10%
31. Chronic Renal Insufficiency 10%
32. Rehabilitation 10%
33. Logistic Models 9%
34. Traumatic Brain Injury 9%
35. Quality of Life 9%
36. Liver 9%
37. Serum 9%
38. Arsenic 9%
39. Inflammation 9%
40. Bipolar Disorder 9%
41. Chronic Obstructive Pulmonary Disease 9%
42. Diet 9%
43. Pain 9%
44. Datasets 8%
45. Hepatocellular Carcinoma 8%
46. Schizophrenia 8%
47. Blood Pressure 8%
48. Heart Rate 8%
49. Obesity 8%
50. Neoplasm Metastasis 8%
51. Machine Learning 8%
52. Delivery of Health Care 8%
53. Case-Control Studies 8%
54. Survival 8%
55. Lung Neoplasms 7%
56. Lung 7%
57. Parkinson Disease 7%
58. Brain 7%
59. Cognitive Dysfunction 7%
60. Mucocutaneous Lymph Node Syndrome 7%
61. Lipids 7%
62. Kidney 7%
63. Cognition 7%
64. Child 7%
65. Anxiety 7%
66. Cross-Sectional Studies 7%
67. Equipment and Supplies 7%
68. Lipopolysaccharides 7%
69. Up-Regulation 6%
70. Psychometrics 6%
71. Hypertension 6%
72. Nursing 6%
73. Reproducibility of Results 6%
74. Physicians 6%
75. Body Mass Index 6%
76. Spinal Cord Injuries 6%
77. Biomarkers 6%
78. Electronic Health Records 6%
79. Body Composition 6%
80. Tomography 6%
81. Sleep Initiation and Maintenance Disorders 6%
82. Education 6%
83. Type 2 Diabetes Mellitus 6%
84. Gene Expression 6%
85. Calcium 6%
86. Pressure 6%
87. Fats 6%
88. Electric Stimulation 6%
89. Appointments and Schedules 6%
90. Muscles 6%
91. Macrophages 6%
92. Urinary Bladder 6%
93. Growth 5%
94. Weight Loss 5%
95. Single Nucleotide Polymorphism 5%
96. Comorbidity 5%
97. Hand 5%
98. Retrospective Studies 5%